The field of Epigenetics is gathering momentum and correlating epigenetic changes with clinical parameters is well characterized given the abundance of scientific literature published to date. There is however, a distinct paucity of markers that have been translated into clinical practice. Dr Snuderl discusses some of the technologies that are being adopted at NYU Health and how these are helping drive this important field forward. Today’s podcast is sponsored by Illumina.
Panelists:
Matija Snuderl, MD
Associate Professor, Department of Pathology
Director Molecular Pathology
NYU Langone Health
Damian Doherty
Editor in Chief
Inside Precision Medicine
